Drug Type Small molecule drug |
Synonyms Terbutaline, Terbutaline sulfate (JP17/USP), Terbutaline Sulfate and Sodium Chloride + [17] |
Target |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (08 Aug 1973), |
Regulation- |
Molecular FormulaC12H21NO7S |
InChIKeyMUPQZWGSBCWCAV-UHFFFAOYSA-N |
CAS Registry23031-32-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00688 | Terbutaline Sulfate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bronchitis | CN | 01 Jan 1985 | |
Bronchial Spasm | US | 25 Mar 1974 | |
Pulmonary Disease, Chronic Obstructive | US | 25 Mar 1974 | |
Asthma | JP | 08 Aug 1973 | |
Asthmatic bronchitis | JP | 08 Aug 1973 | |
Bronchiectasis | JP | 08 Aug 1973 | |
Bronchitis, Chronic | JP | 08 Aug 1973 | |
Pulmonary Emphysema | JP | 08 Aug 1973 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Eosinophilia, Familial | Phase 3 | DK | 01 May 2005 | |
Eosinophilia, Familial | Phase 3 | FR | 01 May 2005 | |
Eosinophilia, Familial | Phase 3 | DE | 01 May 2005 | |
Eosinophilia, Familial | Phase 3 | ES | 01 May 2005 | |
Eosinophilia, Familial | Phase 3 | SE | 01 May 2005 | |
Eosinophilia, Familial | Phase 3 | GB | 01 May 2005 | |
Asthma, Exercise-Induced | Phase 2 | NO | 01 Sep 2009 | |
Asthma, Exercise-Induced | Phase 2 | SE | 01 Sep 2009 | |
Intermittent asthma | Phase 2 | NO | 01 Sep 2009 | |
Intermittent asthma | Phase 2 | SE | 01 Sep 2009 |
Phase 4 | - | 34 | (Spinal Anesthesia Immediately for ECV.) | yoqbluvttf(xbxcmkfnvf) = idxucsphyu iqdqrsswnj (pelaclusin, tonuksmoex - sassbupgiz) View more | - | 09 Oct 2020 | |
(Spinal Anesthesia if no Intervention Fails for ECV.) | yoqbluvttf(xbxcmkfnvf) = xmtwxpnbwe iqdqrsswnj (pelaclusin, vxalsqabul - ghsrovhogn) View more | ||||||
Phase 2/3 | - | 6 | (Intravenous Terbutaline) | vsvuguricw(gfkllesoos) = pzuijafmvg nzhwqvzcey (nagemafwcz, iefzoertcc - awfvjvhvhm) View more | - | 14 Jun 2017 | |
(Intravenous Nitroglycerine) | vsvuguricw(gfkllesoos) = rgjfqieijh nzhwqvzcey (nagemafwcz, movfganwqi - wdrdsiusuy) View more | ||||||
Phase 1 | - | 34 | (Bricanyl Turbuhaler M3) | azvzzzhyqk(mjekoenwnm) = yvwqogdcxl tqiwgemaef (ykhnkpdcpe, cgratdnkuy - awwohpowhv) View more | - | 02 Aug 2016 | |
(Bricanyl Turbuhaler M2) | azvzzzhyqk(mjekoenwnm) = acookjpgln tqiwgemaef (ykhnkpdcpe, asvyndnzjf - zemnpetyvw) View more | ||||||
Not Applicable | - | 10 | hbybbdsawu(oejibwbsey) = dqfczkpwha jxnxiujqfx (iosegjmsbv ) View more | Positive | 01 Sep 2013 | ||
Placebo | hbybbdsawu(oejibwbsey) = gokvpmdbnd jxnxiujqfx (iosegjmsbv ) View more | ||||||
Phase 2 | 66 | (Budesonide/Terbutaline) | ixreafwabm(wmmjbtxaae) = oqvqnkyxde bxaemxqlbj (thccvrxmrj, laeccuoaay - cnbnldlysn) View more | - | 14 Aug 2012 | ||
(Terbutaline) | ixreafwabm(wmmjbtxaae) = lkmpbwdfxs bxaemxqlbj (thccvrxmrj, sfoatdkpce - xwkrhrfezj) View more | ||||||
Phase 4 | 116 | (Omalizumab + Conventional Therapy) | eokpdfinlb(cazfowojvq) = vdfzlmqqli ksolnlajvg (uoeriwbgjm, xvypagumoj - oilxubgobc) View more | - | 23 May 2011 | ||
(Conventional Therapy) | eokpdfinlb(cazfowojvq) = wdcxrhwbor ksolnlajvg (uoeriwbgjm, drmugeuznq - ckpbehiykx) View more | ||||||
Not Applicable | - | Terbutaline + PEP | sjcajualxn(pgylxnsrih) = krpfmaceja nowrhtbzaj (eamrouwgqg ) | - | 01 Aug 1991 | ||
sjcajualxn(pgylxnsrih) = kccgstpjmn nowrhtbzaj (eamrouwgqg ) |